Loading…

Semiautomated determination of neonicotinoids and characteristic metabolite in urine samples using TurboFlow™ coupled to ultra high performance liquid chromatography coupled to Orbitrap analyzer

[Display omitted] •Seven neonicotinoids and one metabolite have been determined by LC-Orbitrap.•Two online extraction systems were evaluated: TurboFlow™ and SPE.•Thirty six urine samples were analyzed by the developed method.•Three neonicotinoids and one metabolite were detected in urine samples. A...

Full description

Saved in:
Bibliographic Details
Published in:Journal of pharmaceutical and biomedical analysis 2017-11, Vol.146, p.378-386
Main Authors: López-García, Marina, Romero-González, Roberto, Lacasaña, Marina, Garrido Frenich, Antonia
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:[Display omitted] •Seven neonicotinoids and one metabolite have been determined by LC-Orbitrap.•Two online extraction systems were evaluated: TurboFlow™ and SPE.•Thirty six urine samples were analyzed by the developed method.•Three neonicotinoids and one metabolite were detected in urine samples. A semiautomated method based on ultra-high performance liquid chromatography (UHPLC) coupled to Orbitrap high resolution mass spectrometry has been developed for the determination of neonicotinoids (imidacloprid, acetamiprid, clothianidin, dinotefuran, nitenpyram, thiacloprid and thiamethoxam) and the metabolite acetamiprid-n-desmethyl in urine samples. Two automated methods were tested (solid-phase extraction “SPE” and turbulent flow chromatography “TurboFlow™”), obtaining the best results when TurboFlow™ was applied. The total analysis time for the developed method was 14min. The optimized method was validated, obtaining suitable results for all validation parameters. Recoveries ranged from 78% to 116% meanwhile repeatability and reproducibility were evaluated obtaining values lower than 10% and 20% respectively (except for dinotefuran and nitenpyram at 0.2μgL−1). The limit of quantification (LOQ) for all compounds was established at 0.2μgL−1. The proposed analytical methodology was applied to analyze the target compounds in thirty six urine samples from pregnant women living in agricultural areas of Almería (Spain). Imidacloprid, acetamiprid and acetamiprid-n-desmethyl were detected in some of the samples at concentrations ranging from 0.23 to 1.57μgL−1. Furthermore, dinotefuran was identified in two samples at trace levels.
ISSN:0731-7085
1873-264X
DOI:10.1016/j.jpba.2017.08.026